$PYXS
Pyxis Oncology, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.21
▲+3.45%+$0.074
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePyxis Oncology, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PYXS up today? It is at $2.21 (+3.45%), and our scanner flagged it 116 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PYXS spikes, and full due diligence on PYXS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PYXS 116 times in the last 30 days. Create a free account to track $PYXS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PYXS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on PYXS today, peaking at 27.3x its normal volume.
Likely catalystPriced share offering, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedOct 5, 2026 · todayAcross every filing on file, supply equal to 253.6% of the tradeable float is in play - 201.4% has already been sold, and 52.2% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
87,241,392 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Gordonmd Global Investments Lp Beneficial Owner (10%) | Acquired (grant/award) | +5.52M 6.6% of company | added 55% | 15.54M | n/a | Oct 1, 26 |
Dupont Jakob Director | Sold (automatic/other) | -35K 0.04% of company | sold 47% | 39K | $107K at $3.06 | Jun 30, 26 |
Dupont Jakob Director | Other | 35K 0.04% of company | added 90% | 74K | $56K at $1.60 | Jun 30, 26 |
Wadhane Jitendra Officer | Acquired (grant/award) | +109K 0.1% of company | added 27% | 513K | n/a | Mar 24, 26 |
Humphrey Rachel Director | Sold (automatic/other) | -14K 0.02% of company | sold 15% | 81K | $14K at $1.03 | Apr 21, 25 |
Humphrey Rachel Director | Sold (automatic/other) | -200 | sold 0.2% | 95K | $194 at $0.970 | Apr 17, 25 |
Humphrey Rachel Director | Sold (automatic/other) | -1K | sold 1.4% | 95K | $1K at $0.970 | Apr 14, 25 |
Connealy Pamela Ann Officer | Bought (open market) | +89K 0.1% of company | added 4.0% | 2.31M | $174K at $1.96 | Nov 26, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
PYXS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on PYXS today, peaking at 27.3x its normal volume.
PYXS last traded at $2.21, up 3.45% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pyxis Oncology, Inc. Common Stock (PYXS) is next expected to report earnings on Monday, November 2, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PYXS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PYXS 116 times in the last 30 days.
PYXS (Pyxis Oncology, Inc. Common Stock) trades on XNAS, with a market cap of about $178M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PYXS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PYXS discussion
Sign in to ask a question or join the discussion.